Arkansas Heart Hospital
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Arkansas Heart Hospital sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Arkansas Heart Hospital: 7 sponsored US clinical trials, none currently recruiting.
Arkansas Heart Hospital sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Peripheral Arterial Disease, with 2 trials.
Upper-quartile sponsor footprint
Arkansas Heart Hospital sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Effects of 9-18 Weeks of Intensive Cardiac Rehabilitation After a Major Cardiovascular Event in Patients With CVD
NCT05708313
Diamondback in Peripheral Vascular Disease
NCT03455374
Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the SFA (DESPERADO-SFA Study)
NCT02734836
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
NCT02741362
Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD
NCT02756884
Ticagrelor and Peripheral Arterial Disease
NCT02407314
Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPD
NCT02161744
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 4 | 1 |
Therapeutic Areas
How the Arkansas Heart Hospital early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 3 completed (43%).
Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Peripheral Arterial Disease (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Arkansas Heart Hospital: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Arkansas Heart Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Arkansas Heart Hospital page
7 registered trials is a research-attention snapshot, not an endorsement of Arkansas Heart Hospital or any single study.
- None of Arkansas Heart Hospital's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Peripheral Arterial Disease is the condition Arkansas Heart Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Peripheral Arterial Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Arkansas Heart Hospital pipeline card: 7 registered trials from official public datasets.Report a data error.